Literature DB >> 33751501

Neurocognitive Endophenotypes of OCD.

Matilde M Vaghi1.   

Abstract

In this chapter, I address the concept of endophenotypes for obsessive-compulsive disorder (OCD). Endophenotypes are objective and heritable quantitative traits hypothesized to be more biologically tractable than distal clinical phenotypes. This approach has been adopted to gain a better understanding of psychiatric conditions in general. It is theorized that endophenotypes will particularly assist in clarifying both the diagnostic status and aetiological origins of complex neuropsychiatric conditions such as OCD. At the cognitive level, separable constructs of relevance for OCD have been identified. The prevailing model for OCD assumes the development of abnormalities within fronto-striatal neural circuits leading to impairment of executive functions and their neuropsychological subcomponents. Here, I address whether this model can guide towards the identification of endophenotypes for this condition and discuss possible implications.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Endophenotype; Executive functions; Obsessive-compulsive disorder

Year:  2021        PMID: 33751501     DOI: 10.1007/7854_2020_197

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  131 in total

1.  The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding.

Authors:  M Abbruzzese; S Ferri; S Scarone
Journal:  Neuropsychologia       Date:  1997-06       Impact factor: 3.139

2.  Heritability of frontal brain function related to action monitoring.

Authors:  Andrey P Anokhin; Simon Golosheykin; Andrew C Heath
Journal:  Psychophysiology       Date:  2008-05-20       Impact factor: 4.016

3.  Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Tricia Sicard; Eliza Burroughs; Margaret A Richter; James L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2006-07

4.  The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis.

Authors:  Amitai Abramovitch; Jonathan S Abramowitz; Andrew Mittelman
Journal:  Clin Psychol Rev       Date:  2013-09-29

5.  Neural systems engaged by planning: a PET study of the Tower of London task.

Authors:  S C Baker; R D Rogers; A M Owen; C D Frith; R J Dolan; R S Frackowiak; T W Robbins
Journal:  Neuropsychologia       Date:  1996-06       Impact factor: 3.139

6.  Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Authors:  Paul D Arnold; David R Rosenberg; Emanuela Mundo; Subi Tharmalingam; James L Kennedy; Margaret A Richter
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

7.  Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naïve patients.

Authors:  Pedro G Alvarenga; Maria C do Rosário; Marcelo C Batistuzzo; Juliana B Diniz; Roseli G Shavitt; Fábio L S Duran; Darin D Dougherty; Rodrigo A Bressan; Eurípedes C Miguel; Marcelo Q Hoexter
Journal:  J Psychiatr Res       Date:  2012-10-04       Impact factor: 4.791

8.  Response inhibition deficits in obsessive-compulsive disorder.

Authors:  Shelley Bannon; Craig J Gonsalvez; Rodney J Croft; Philip M Boyce
Journal:  Psychiatry Res       Date:  2002-06-01       Impact factor: 3.222

9.  Wisconsin Card Sorting Test performance in obsessive-compulsive disorder: no evidence for involvement of dorsolateral prefrontal cortex.

Authors:  M Abbruzzese; S Ferri; S Scarone
Journal:  Psychiatry Res       Date:  1995-09-08       Impact factor: 3.222

10.  Aberrant error processing in relation to symptom severity in obsessive-compulsive disorder: A multimodal neuroimaging study.

Authors:  Yigal Agam; Jennifer L Greenberg; Marlisa Isom; Martha J Falkenstein; Eric Jenike; Sabine Wilhelm; Dara S Manoach
Journal:  Neuroimage Clin       Date:  2014-06-17       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.